Home » Topics » BioWorld Science

BioWorld Science
RSS

Hybridon's GEM-91 inhibits various steps in HIV-1 replication

July 19, 1996

Cel-Sci's HGP-30 vaccine associated with IgG3 isotype antibody response

July 19, 1996

Zadaxin/zidovudine/interferon alpha combination enhances immune system

July 19, 1996

Theratechnologies' AIDS gene therapy shows promising results

July 19, 1996

Triple anti-HIV therapy shows positive results

July 19, 1996

Protease inhibitor plus Epivir/Retrovir cocktail shows positive anti-HIV results

July 19, 1996

Pharmacia & Upjohn seeks FDA approval for Rescriptor

July 19, 1996

Cantab's DISC HSV-2 cleared in U.K. for testing in genital herpes

July 19, 1996

Antibacterial benzimidazole derivatives from Roche

July 19, 1996

Saricandin: Abbott's novel papulacandin antifungal antibiotic

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.